slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 18,554
Current window 2,611-2,640
Pages 619
Rows per page 30
Component
2,611-2,640 of 18,554
159
Uses pull-quotes as primary evidence to support the 'villain' critique of the target company's economic viability.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
172
Uses a quote from Steve LeVine (Quartz) and a photo of Obama with Sakti3 founder to establish credibility and highlight the 'hype' narrative.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
173
The slide uses a 'before-after' style comparison to frame Quantumscape as a repeat of the Sakti3 fraud.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
184
The slide uses expert testimony to debunk the company's timeline and valuation.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
186
The slide uses direct quotes to undermine the credibility of the CEO's projections.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
03
The slide uses anonymous expert testimony to undermine the company's clinical trial integrity and market prospects.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
109
The slide uses direct quotes from medical experts to highlight a potential flaw in the company's clinical approach.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
154
The slide uses direct quotes from pediatric endocrinologists to highlight safety concerns, specifically referencing the drug's potential to exacerbate existing cardiac risks in PWS patients.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
189
The slide uses a Q&A format to present qualitative evidence of investigator misconduct.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
191
The slide uses direct quotes from investigators to undermine the clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
216
Uses direct quotes from interviews to undermine the value proposition of the target company's product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
225
The slide uses direct quotes from an expert consultation to undermine the credibility of the drug's approval and market potential.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
233
The slide uses a Q&A transcript format to validate the activist's thesis regarding data manipulation and competitive threat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
244
The slide uses direct quotes to build a case of corporate malfeasance regarding safety disclosures.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
251
The slide uses a Q&A format to highlight inconsistencies in clinical trial reporting.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
252
The slide uses direct quotes from a KOL to undermine the company's marketing narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
254
The slide uses direct quotes to frame the problem of insurance access as a deliberate strategy of 'playing chicken' by insurers.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
255
The slide uses direct quotes to frame the company's actions as predatory and unethical.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
268
The slide uses a direct quote to highlight a conflict of interest or professional disagreement regarding medical standards.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
271
The slide uses direct quotes to expose the insurer's strategy of forcing generic/compounded substitution to save costs.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
273
The slide uses expert quotes to undermine the perceived market opportunity for Soleno.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
287
The slide highlights a potential safety risk identified by a KOL regarding the drug's mechanism of action.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
291
Uses direct quotes from a trial investigator to undermine the validity of clinical trial data.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
305
The slide uses direct quotes from a trial investigator to undermine the drug's market potential and clinical efficacy.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
311
The slide uses a Q&A format to document expert testimony regarding trial integrity.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
313
The slide uses a Q&A format to highlight the expert's skepticism about the company's reporting practices.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
325
The slide uses direct quotes from a pediatric endocrinologist to build a case against the drug's safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
330
Includes direct Q&A transcripts from a trial investigator/endocrinologist.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
333
The slide uses direct quotes from a trial investigator to undermine the company's value proposition.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
335
The slide uses direct quotes from an interview to highlight the discrepancy between public promotion and private clinical reality.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits